GlassScriptPhysician profile
Oliver E Carlota
NPI 1407882525
$834.75
in general payments reported to CMS, 2019-2025
19 companies · $295 in 2025
The $295 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $40.53 · 2021: $60.08 · 2022: $76.61 · 2023: $143 · 2024: $112 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $549.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $103.79 | 2019-2021 | |
| Astellas Pharma US INC | $96.45 | 2023-2024 | Veozah, Myrbetriq |
| Sage Therapeutics, LLC | $86.01 | 2025 | Zurzuvae |
| Pfizer INC. | $75.06 | 2023-2025 | |
| Daiichi Sankyo INC. | $54.02 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $52.92 | 2025 | |
| Hologic Sales and Service, LLC | $41.95 | 2023-2025 | Acessa Provu System, Novasure |
| Supernus Pharmaceuticals, INC. | $41.88 | 2025 | Qelbree |
| Organon LLC | $40.00 | 2022 | |
| Sumitomo Pharma America, INC. | $39.88 | 2024 | Gemtesa |
| Shield Therapeutics INC | $36.55 | 2025 | |
| Abbvie INC. | $33.44 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Minerva Surgical, INC | $28.18 | 2025 | |
| Scynexis, INC. | $20.71 | 2022 | |
| Coopersurgical, INC. | $19.49 | 2024 | Summit Doppler |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $18.12 | 2021 | |
| Axonics, INC. | $17.44 | 2024 | Axonics |
| Mayne Pharma Commercial LLC | $15.90 | 2022 | |
| Agile Therapeutics, INC. | $12.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oliver Carlota listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.